• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为向继发进展型多发性硬化症转变的人群构建用户主导资源:一项国际名义小组研究的结果

Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study.

作者信息

Giovannetti Ambra Mara, Barabasch Anna, Giordano Andrea, Quintas Rui, Barello Serena, Graffigna Guendalina, Alfieri Sara, Schiffmann Insa, Muche-Borowski Cathleen, Borreani Claudia, Heesen Christoph, Solari Alessandra

机构信息

Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Unit of Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

出版信息

Front Neurol. 2020 Aug 18;11:798. doi: 10.3389/fneur.2020.00798. eCollection 2020.

DOI:10.3389/fneur.2020.00798
PMID:33013615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7461961/
Abstract

ManTra is a mixed-methods, co-production research project for developing an intervention (resource) for people with newly diagnosed secondary progressive multiple sclerosis (pwSPMS) in Italy and Germany. In previous project actions, six resources were outlined, meeting the needs prioritized by pwSPMS. This study aims to achieve multiple-stakeholder consensus on the most suitable resource and to refine the consensus resource. Two nominal group technique (NGT) meetings were held, one in Milan and one in Hamburg. Participants were pwSPMS (five in Italy/six in Germany), pwSPMS significant others (SOs, four/five), healthcare professionals (HPs, seven/four), and health service researchers/patient and citizen organizations representatives (HPCORs, five/five). Two of the four resources discussed in each meeting were the same in Italy and Germany: "Promoting the engagement of pwSPMS: a program for the patients and the HPs" and "Enriched physiotherapy program for pwSPMS." The other two were "A personalized care plan for pwSPMS" and "Roadmap for social and economic benefits" in Italy and "Metacognitive and everyday life training for pwSPMS" and "Psychological support for pwSPMS" in Germany. Each meeting consisted of two plenary sessions and a parallel group session (four stakeholder groups: pwSPMS, SOs, HPs, and HPCORs) in between. Meetings' narratives were analyzed thematically. The two meetings were rich in participation and discussion. In Italy, the consensus resource was "A personalized care plan for pwSPMS." Refinements included enrichment with pwSPMS engagement, inclusion of additional HPs, improved definition of the MS nurse's role within the interdisciplinary panel, and community care integration. In Germany, the consensus resource was "Psychological support for pwSPMS." Refinements included reshaping this resource into a more comprehensive and adaptive rehabilitation intervention and training the psychologist in recognizing client's rehabilitative needs and enhancing his/her autonomy. The NGT eased multiple-stakeholder deliberation and resource fine-tuning in both countries.

摘要

ManTra是一个混合方法的联合生产研究项目,旨在为意大利和德国新诊断为继发进展型多发性硬化症(pwSPMS)的患者开发一种干预措施(资源)。在之前的项目行动中,概述了六种资源,满足了pwSPMS患者优先考虑的需求。本研究旨在就最合适的资源达成多利益相关方共识,并完善该共识资源。举行了两次名义小组技术(NGT)会议,一次在米兰,一次在汉堡。参与者包括pwSPMS患者(意大利5名/德国6名)、pwSPMS患者的重要他人(SOs,意大利4名/德国5名)、医疗保健专业人员(HPs,意大利7名/德国4名)以及卫生服务研究人员/患者和公民组织代表(HPCORs,意大利5名/德国5名)。每次会议讨论的四种资源中有两种在意大利和德国是相同的:“促进pwSPMS患者的参与:针对患者和医疗保健专业人员的项目”以及“针对pwSPMS患者的强化物理治疗项目”。另外两种在意大利是“针对pwSPMS患者的个性化护理计划”和“社会和经济效益路线图”,在德国是“针对pwSPMS患者的元认知和日常生活训练”以及“针对pwSPMS患者的心理支持”。每次会议包括两次全体会议以及中间的一次平行小组会议(四个利益相关方小组:pwSPMS患者、SOs、HPs和HPCORs)。对会议记录进行了主题分析。这两次会议参与度高且讨论热烈。在意大利,共识资源是“针对pwSPMS患者的个性化护理计划”。完善内容包括增加pwSPMS患者的参与度、纳入更多医疗保健专业人员、改进跨学科小组中多发性硬化症护士角色的定义以及整合社区护理。在德国,共识资源是“针对pwSPMS患者 的心理支持”。完善内容包括将该资源重塑为更全面、适应性更强的康复干预措施,并对心理学家进行培训,使其能够识别患者的康复需求并增强其自主性。名义小组技术在两国都促进了多利益相关方的审议和资源微调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/859f/7461961/658407812d07/fneur-11-00798-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/859f/7461961/658407812d07/fneur-11-00798-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/859f/7461961/658407812d07/fneur-11-00798-g0001.jpg

相似文献

1
Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study.为向继发进展型多发性硬化症转变的人群构建用户主导资源:一项国际名义小组研究的结果
Front Neurol. 2020 Aug 18;11:798. doi: 10.3389/fneur.2020.00798. eCollection 2020.
2
Managing the transition (ManTra): a resource for persons with secondary progressive multiple sclerosis and their health professionals: protocol for a mixed-methods study in Italy.管理过渡阶段(ManTra):面向继发进展型多发性硬化症患者及其医疗专业人员的资源:意大利一项混合方法研究的方案
BMJ Open. 2017 Aug 23;7(8):e017254. doi: 10.1136/bmjopen-2017-017254.
3
Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.转化为继发进展型多发性硬化症:意大利多利益相关方的经验和需求。
PLoS One. 2020 Feb 13;15(2):e0228587. doi: 10.1371/journal.pone.0228587. eCollection 2020.
4
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.转化为继发进展型多发性硬化症:患者的认知与需求。意大利和德国在线调查结果
Front Neurol. 2019 Aug 22;10:916. doi: 10.3389/fneur.2019.00916. eCollection 2019.
5
Development of a balance, safe mobility and falls management programme for people with multiple sclerosis.为多发性硬化症患者制定平衡、安全移动性和跌倒管理计划。
Disabil Rehabil. 2018 Dec;40(24):2857-2866. doi: 10.1080/09638288.2017.1362041. Epub 2017 Aug 7.
6
Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.促进和支持社区中患有慢性身体疾病的成年人进行自我管理:对医患互动的有效性和意义的系统评价。
JBI Libr Syst Rev. 2009;7(13):492-582. doi: 10.11124/01938924-200907130-00001.
7
Erratum.勘误
Mult Scler. 2016 Oct;22(12):NP9-NP11. doi: 10.1177/1352458515585718. Epub 2015 Jun 3.
8
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial.机器人辅助步态训练与传统疗法对重度残疾进展性多发性硬化症患者活动能力的疗效比较(RAGTIME):一项随机对照试验的研究方案
Trials. 2017 Feb 27;18(1):88. doi: 10.1186/s13063-017-1838-2.
9
Barriers and solutions to participation in exercise for moderately disabled people with multiple sclerosis not currently exercising: a consensus development study using nominal group technique.目前不参加锻炼的中度残疾多发性硬化症患者参与锻炼的障碍和解决方案:使用名义群体技术的共识发展研究。
Disabil Rehabil. 2019 Nov;41(23):2775-2783. doi: 10.1080/09638288.2018.1479456. Epub 2018 Jun 29.
10
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting.糖尿病肾病患者精准医疗实施的前进方向展望;利益相关者共识达成会议的结果
Front Pharmacol. 2021 May 4;12:662642. doi: 10.3389/fphar.2021.662642. eCollection 2021.

引用本文的文献

1
Promoting participatory research in chronicity: The ESPRIMO biopsychosocial intervention for young adults with multiple sclerosis.促进慢性病领域的参与式研究:针对患有多发性硬化症的年轻人的ESPRIMO生物心理社会干预措施。
Front Psychol. 2022 Nov 3;13:1042234. doi: 10.3389/fpsyg.2022.1042234. eCollection 2022.
2
A nurse-led, telephone-based patient support program for improving adherence in patients with relapsing-remitting multiple sclerosis using interferon beta-1a: Lessons from a consumer-based survey on adveva PSP.一项由护士主导、基于电话的患者支持项目,旨在提高复发缓解型多发性硬化症患者使用β-1a干扰素的依从性:来自关于Adveva PSP基于消费者的调查的经验教训。
Front Psychol. 2022 Aug 24;13:965229. doi: 10.3389/fpsyg.2022.965229. eCollection 2022.
3

本文引用的文献

1
Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.转化为继发进展型多发性硬化症:意大利多利益相关方的经验和需求。
PLoS One. 2020 Feb 13;15(2):e0228587. doi: 10.1371/journal.pone.0228587. eCollection 2020.
2
Content and Delivery of Physical Therapy in Multiple Sclerosis across Europe: A Survey.欧洲多发性硬化症的物理治疗内容和方法:一项调查。
Int J Environ Res Public Health. 2020 Jan 31;17(3):886. doi: 10.3390/ijerph17030886.
3
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.
Experiences of persons with multiple sclerosis with rehabilitation-a qualitative interview study.多发性硬化症患者的康复体验——一项定性访谈研究。
BMC Health Serv Res. 2022 Jun 11;22(1):770. doi: 10.1186/s12913-022-08150-8.
转化为继发进展型多发性硬化症:患者的认知与需求。意大利和德国在线调查结果
Front Neurol. 2019 Aug 22;10:916. doi: 10.3389/fneur.2019.00916. eCollection 2019.
4
Multiple challenges for people after transitioning to secondary progressive multiple sclerosis: a qualitative study.继发进展型多发性硬化患者转归后的多重挑战:一项定性研究。
BMJ Open. 2019 Mar 8;9(3):e026421. doi: 10.1136/bmjopen-2018-026421.
5
Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis.感知需求与服务提供之间的差距:一项横断面研究意大利多发性硬化症患者。
Neurol Sci. 2019 Jun;40(6):1137-1144. doi: 10.1007/s10072-019-03780-z. Epub 2019 Feb 27.
6
Self-stigma and the intention to seek psychological help online compared to face-to-face.自我污名化与在线寻求心理帮助的意图,与面对面相比。
J Clin Psychol. 2018 Jul;74(7):1207-1218. doi: 10.1002/jclp.22583. Epub 2018 Jan 8.
7
Managing the transition (ManTra): a resource for persons with secondary progressive multiple sclerosis and their health professionals: protocol for a mixed-methods study in Italy.管理过渡阶段(ManTra):面向继发进展型多发性硬化症患者及其医疗专业人员的资源:意大利一项混合方法研究的方案
BMJ Open. 2017 Aug 23;7(8):e017254. doi: 10.1136/bmjopen-2017-017254.
8
Defining secondary progressive multiple sclerosis.定义继发进展型多发性硬化症。
Brain. 2016 Sep;139(Pt 9):2395-405. doi: 10.1093/brain/aww173. Epub 2016 Jul 7.
9
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis.一项评估复发缓解型和继发进展型多发性硬化症细胞因子水平概况的临床与实验室研究。
J Neuroimmunol. 2015 Jan 15;278:53-9. doi: 10.1016/j.jneuroim.2014.12.005. Epub 2014 Dec 5.
10
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.一种2型生物标志物可区分复发缓解型多发性硬化症与继发进展型多发性硬化症。
Neurology. 2014 Oct 21;83(17):1492-9. doi: 10.1212/WNL.0000000000000905. Epub 2014 Sep 24.